Clinical trial
Is Intraligamentary Injection the Anesthesia of Choice for Symptomatic Irreversible Pulpitis in Mandibular Molars? A Multicenter Randomized Comparative Trial.
NCT07130760 is registered in ClinicalTrials.gov with Aula Dental Avanzada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Intraligamentary Injection the Anesthesia of Choice for Symptomatic Irreversible Pulpitis in Mandibular Molars? A Multicenter Randomized Comparative Trial.
- Lead sponsor
- Aula Dental Avanzada
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 20, 2025
- Completion date
- July 31, 2027
- Enrollment
- 52 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
dental pain, inferior alveolar nerve block failure, local anesthesia, symptomatic irreversible pulpitis (sip)